Important Resources

Learn More About ALUNBRIG®

Patient Brochure Patient Brochure
Patient Brochure

Stay Connected

Join now to receive useful information and updates about ALUNBRIG.

Register Today

Support When You Need It


ALUNBRUG BRIGATINIB
is a financial assistance and support program for you

  • ARIADPASS Access

    ACCESS: A Patient Access Specialist can work with you and your healthcare provider’s office to conduct a benefits investigation and provide you both with details on your drug coverage and options

  • ARIADPASS Afford

    AFFORD: Regardless of your insurance status, ALUNBRIG 1Point can help identify an array of financial assistance programs for which you may be eligible

    • To determine your eligibility and enroll for the ALUNBRIG Co-Pay Assistance Program, visit www.ALUNBRIGCOPAY.com or call 1-844-A1POINT (1-844-217-6468)
    • To determine your eligibility for other financial assistance programs, visit the ALUNBRIG 1Point website
  • ARIADPASS Assure

    ASSIST: ALUNBRIG 1Point is committed to supporting you throughout your treatment by providing you with support services to get you the information you need, and assist with day-to-day concerns associated with your treatment

  • Click the button below or call 1-844-A1POINT (1-844-217-6468) for information on ALUNBRIG 1Point.

Resources That May Be Useful

We hope you will use the resources above to find the people, tools, and education that will enable you to become an active participant in your care. Takeda Oncology is not affiliated with these organizations. By listing these resources, Takeda Oncology is not endorsing any particular service or group and we are not responsible for the content of these sites or services. They are provided here for informational purposes and are not meant to replace your healthcare provider's medical advice.

ALUNBRIG(TM) BRIGATINIB 39 mg TABLETS

This site is intended for residents
of the US and US territories only.

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib) and entering one that is not owned or controlled by Takeda Oncology.

Takeda Oncology makes no representation as to the accuracy of the information contained on sites we do not own or control. Takeda Oncology does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel Continue >
Close

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib) and entering one that is not owned or controlled by Takeda Oncology.

This link will take you to the corporate ARIAD Pharmaceuticals, Inc. website.

Cancel Continue >
Close

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib).

This link will take you to another Takeda Oncology website.

Cancel Continue >
Close

The site you are about to enter is intended for US healthcare professionals only.

Please confirm that you are a US healthcare professional.

Yes, I confirm that I am a US healthcare professional Cancel
Close